Clinical Trial Update: Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on intranasal neuropeptide Y for PTSD and acute stress disorder in Level Two trauma patients, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder
• Stress Disorder

Drugs mentioned

• Intranasal Neuropeptide Y (neuropeptide Y)

Snippet

Sponsor: New York Medical College | Conditions: Stress Disorders, Post-Traumatic, Stress Disorders, Traumatic, Acute | Phase 1, Phase 2 | Status: UNKNOWN